Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Cartherics to present at ThymOz 2023

By Karen Loudon / March 22, 2023
Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March...
Read More

Cartherics to present at prestigious oncology conference in France

By Karen Loudon / March 3, 2023
Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in...
Read More

Cartherics to present at Australia Biologics 2023

By Karen Loudon / February 28, 2023
Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown...
Read More
1 2 3 47